Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

7.36

0.00 (0.00%)

At close: Feb 2, 2026, 4:00 PM EST

7.57

+0.21 (2.82%)

After-hours: Feb 2, 2026, 7:40 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Gvoke, Keveyis and Recorlev	153.36M
Gvoke, Keveyis and Recorlev Growth	40.36%
Royalty, Contract and Other	10.55M
Royalty, Contract and Other Growth	971.07%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.